Octave Announces Publication of Analytical Validation Study Results in Nature Communications More
Octave Announces Publication of Analytical Validation Study Results in Nature Communications More
Octave offers support to patients in understanding and managing the insurance and billing aspects related to the Octave MSDA Test. Our team is here to support any questions you may have on insurance billing, cash pay payment options, financial assistance programs, flexible payment options and appealing claims which may be denied.
The Octave Multiple Sclerosis Disease Activity (MSDA) Test is the first and only multivariate biomarker blood test that provides accurate measurement of MS disease activity.
We’re empowering patients and providers by providing tools to make confident care decisions. You can learn more about our test here.
Octave is committed to making our solution affordable and accessible to all patients. The amount you may owe for The Octave MSDA Test can vary based on your health insurance plan and benefits. After we receive your blood sample, Octave will either submit a claim to your insurance or bill you in the absence of insurance or for any balance after your insurance processes a claim.
For patients who owe a portion of the MSDA Test cost, Octave provides multiple payment options customized to suit the needs of our patients. Our Patient Access team is available to help you learn more about your potential cost and educate you on our multiple payment options, which include:
You may conveniently pay your bill online with a credit card.
To pay online with a credit card, please visit payoctave.com. We accept: Visa, Mastercard, American Express, Discover and Diners Club.
The Financial Assistance Program at Octave is determined by household size and income up to 400% of the Federal Poverty Levels (FPL) for the current calendar year.
For additional questions about Octave’s Financial Assistance Program, please use the button provided to schedule time with a Patient Access team member.
